Search research articles
Contact Us
Filters
Showing results (101-110 of 118) with videos related to
Page
of 12
Sort By:
Neurologia Medico-Chirurgica
|
December 22, 1999
Treatment of intradural paraclinoidal aneurysms
N Miyazawa, H Nukui, S Mitsuka, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)
|
November 20, 2001
Increased natural killer-cell activity is associated with infertile women
H Matsubayashi, T Hosaka, Y Sugiyama, et al.
Journal of Cardiography
|
September 1, 1985
[Aortic dissection presenting aortic regurgitation induced by diastolic prolapse of an intimal flap into the left ventricle: a case report]
O Yanase, Y Hashimoto, M Nishizaki, et al.
Journal of Viral Hepatitis
|
February 20, 2009
Occult hepatitis B virus infection increases hepatocellular carcinogenesis by eight times in patients with non-B, non-C liver cirrhosis: a cohort study
K Ikeda, M Kobayashi, T Someya, et al.
Kokyu to Junkan. Respiration & Circulation
|
July 1, 1985
[Effect of nifedipine on left ventricular function in patients with dilated cardiomyopathy: evaluation by dynamic exercise echocardiography]
O Yanase, Y Hashimoto, T Hosaka, et al.
Journal of Medicinal Chemistry
|
October 5, 2001
Potent and selective ET-A antagonists. 1. Syntheses and structure-activity relationships of N-(6-(2-(aryloxy)ethoxy)-4-pyrimidinyl)sulfonamide derivatives
H Morimoto, H Shimadzu, E Kushiyama, et al.
Anticancer Research
|
August 15, 1998
Amplification of the CDK4 gene in sarcomas: tumor specificity and relationship with the RB gene mutation
H Kanoe, T Nakayama, H Murakami, et al.
The Tokai Journal of Experimental and Clinical Medicine
|
October 26, 1999
Nurses' perspectives concerning do-not-resuscitate (DNR) orders
T Hosaka, H Nagano, C Inomata, et al.
Journal of Medicinal Chemistry
|
October 5, 2001
Potent and selective ET-A antagonists. 2. Discovery and evaluation of potent and water soluble N-(6-(2-(aryloxy)ethoxy)-4-pyrimidinyl)sulfonamide derivatives
H Morimoto, N Ohashi, H Shimadzu, et al.
Oncogene
|
February 16, 1999
Characteristics of genomic breakpoints in TLS-CHOP translocations in liposarcomas suggest the involvement of Translin and topoisomerase II in the process of translocation
H Kanoe, T Nakayama, T Hosaka, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 118) with videos related to
Sort By:
Page
of 12
Neurologia Medico-Chirurgica
|
December 22, 1999
Treatment of intradural paraclinoidal aneurysms
N Miyazawa, H Nukui, S Mitsuka, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)
|
November 20, 2001
Increased natural killer-cell activity is associated with infertile women
H Matsubayashi, T Hosaka, Y Sugiyama, et al.
Journal of Cardiography
|
September 1, 1985
[Aortic dissection presenting aortic regurgitation induced by diastolic prolapse of an intimal flap into the left ventricle: a case report]
O Yanase, Y Hashimoto, M Nishizaki, et al.
Journal of Viral Hepatitis
|
February 20, 2009
Occult hepatitis B virus infection increases hepatocellular carcinogenesis by eight times in patients with non-B, non-C liver cirrhosis: a cohort study
K Ikeda, M Kobayashi, T Someya, et al.
Kokyu to Junkan. Respiration & Circulation
|
July 1, 1985
[Effect of nifedipine on left ventricular function in patients with dilated cardiomyopathy: evaluation by dynamic exercise echocardiography]
O Yanase, Y Hashimoto, T Hosaka, et al.
Journal of Medicinal Chemistry
|
October 5, 2001
Potent and selective ET-A antagonists. 1. Syntheses and structure-activity relationships of N-(6-(2-(aryloxy)ethoxy)-4-pyrimidinyl)sulfonamide derivatives
H Morimoto, H Shimadzu, E Kushiyama, et al.
Anticancer Research
|
August 15, 1998
Amplification of the CDK4 gene in sarcomas: tumor specificity and relationship with the RB gene mutation
H Kanoe, T Nakayama, H Murakami, et al.
The Tokai Journal of Experimental and Clinical Medicine
|
October 26, 1999
Nurses' perspectives concerning do-not-resuscitate (DNR) orders
T Hosaka, H Nagano, C Inomata, et al.
Journal of Medicinal Chemistry
|
October 5, 2001
Potent and selective ET-A antagonists. 2. Discovery and evaluation of potent and water soluble N-(6-(2-(aryloxy)ethoxy)-4-pyrimidinyl)sulfonamide derivatives
H Morimoto, N Ohashi, H Shimadzu, et al.
Oncogene
|
February 16, 1999
Characteristics of genomic breakpoints in TLS-CHOP translocations in liposarcomas suggest the involvement of Translin and topoisomerase II in the process of translocation
H Kanoe, T Nakayama, T Hosaka, et al.
Page
of 12